Literature DB >> 18668561

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.

Hilal Maradit Kremers1, Cynthia S Crowson, Terry M Therneau, Veronique L Roger, Sherine E Gabriel.   

Abstract

OBJECTIVE: To estimate the 10-year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors to absolute risk assessment.
METHODS: A population-based incidence cohort of RA patients (defined according to the American College of Rheumatology 1987 criteria) was assembled and compared with an age- and sex-matched non-RA cohort. Data were collected on CV risk factors and CV events. Cox regression models were used to estimate the 10-year risk of a combined CV end point, adjusting for CV risk factors. Subjects were classified into 5 risk categories based on their 10-year absolute risk.
RESULTS: The absolute CV risk in RA patients was similar to that in non-RA subjects who were 5-10 years older. The absolute risk varied substantially according to the presence of CV risk factors. The 10-year absolute CV risk among 60-69-year-old RA patients with no risk factors was 16.8%, but rose to 60.4% if risk factors such as smoking, hypertension, dyslipidemia, diabetes, and obesity were present. Among RA patients with a low body mass index, in addition to the above risk factors, the 10-year absolute CV risk rose to 86.2%.
CONCLUSION: More than half of the newly diagnosed RA patients who were 50-59 years of age and all of those >60 years of age had a >10% risk of CV disease within 10 years of their RA incidence and should be targeted for specific CV risk reduction strategies tailored to their personal risk profiles.

Entities:  

Mesh:

Year:  2008        PMID: 18668561      PMCID: PMC2929699          DOI: 10.1002/art.23650

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

Review 1.  When does rheumatoid arthritis begin and why do we need to know?

Authors:  J M Kim; M H Weisman
Journal:  Arthritis Rheum       Date:  2000-03

Review 2.  Treating rheumatoid arthritis early: a window of opportunity?

Authors:  James R O'Dell
Journal:  Arthritis Rheum       Date:  2002-02

3.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 4.  Understanding the window of opportunity concept in early rheumatoid arthritis.

Authors:  Maarten Boers
Journal:  Arthritis Rheum       Date:  2003-07

5.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.

Authors:  Troels F Thomsen; Dan McGee; Michael Davidsen; Torben Jørgensen
Journal:  Int J Epidemiol       Date:  2002-08       Impact factor: 7.196

8.  Rheumatoid factors antedating clinical rheumatoid arthritis.

Authors:  K Aho; M Heliövaara; J Maatela; T Tuomi; T Palosuo
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Authors:  K K Ho; K M Anderson; W B Kannel; W Grossman; D Levy
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

View more
  66 in total

1.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 2.  Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.

Authors:  Elena Myasoedova; John M Davis; Cynthia S Crowson; Sherine E Gabriel
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

3.  Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study.

Authors:  Orla Ni Mhuircheartaigh; Cynthia S Crowson; Sherine E Gabriel; Veronique L Roger; L Joseph Melton; Shreyasee Amin
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

Review 4.  Atherosclerotic vascular disease in the autoimmune rheumatologic patient.

Authors:  Rekha Mankad
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

5.  The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Arun Chandran; Birkan Ilhan; Brittny T Major; C John Michet; Eric L Matteson; Cynthia S Crowson
Journal:  Ann Rheum Dis       Date:  2015-01-30       Impact factor: 19.103

Review 6.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

Review 7.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

8.  Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study.

Authors:  F C Ernste; M Sánchez-Menéndez; K M Wilton; C S Crowson; E L Matteson; H Maradit Kremers
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

9.  Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.

Authors:  Cecilia P Chung; Jon T Giles; Michelle Petri; Moyses Szklo; Wendy Post; Roger S Blumenthal; Allan C Gelber; Pamela Ouyang; Nancy S Jenny; Joan M Bathon
Journal:  Semin Arthritis Rheum       Date:  2012-02       Impact factor: 5.532

Review 10.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.